Fig. 1: Identification criteria for psychiatric samples.
From: Attenuated reward activations associated with cannabis use in anxious/depressed individuals
All participants drawn from the first 500 of the T1000 study35. Participants were initially selected for having any lifetime mood and anxiety disorder diagnosis. The participants who also had a lifetime cannabis dependence diagnosis and excessive past year cannabis use (≥50 uses) comprised the Mood/Anxiety+CB group. The participants with a history of any lifetime mood and anxiety disorder diagnosis and very low lifetime cannabis use (<15 uses) comprised the eligible participants to be sampled from during propensity score-matching.
